Navigation Links
CURE Media Group Launches Educational Video Series to Promote Colorectal Cancer Awareness Month
Date:3/22/2017

In recognition of Colon Cancer Awareness Month, CURE Media Group, the nation’s leading digital and print media enterprise focused on cancer patients, cancer centers and advocacy groups, and MJH Studios™, a leading producer of healthcare video content, has released a special 12-part educational video series, “No Ifs, Ands, or Butts,” that focuses on Colorectal Cancer detection, prevention and management.

Colorectal cancer is a leading cause of cancer death in both men and women in the United States; however, if detected early the disease can be defeated. For this reason, CURE Media Group has developed this special video series to help encourage men and women to get educated on the importance of screening in colon cancer.

“No Ifs, Ands, or Butts,” features the insight of prominent medical experts who play a role in the detection and management of colorectal cancer. Included in the program is Dr. John L. Marshall, medical oncologist at the Reusch Center for the Cure of Gastrointestinal Cancers of Georgetown University, Washington, D.C.; Dr. Thomas Loughney, gastroenterologist at MedStar Georgetown University Hospital, Washington, D.C.; and Jhuli Patel, physician assistant, Gastroenterology, at Saint Peter’s University Hospital in New Brunswick, New Jersey. The medical experts are also joined by Michael Sapienza, CEO of Colon Cancer Alliance in Washington, D.C.

Discussed throughout the series is information regarding what to expect when undergoing a colonoscopy, recognizing barriers to getting screened, and where patients can seek additional support and resources on colorectal cancer and colonoscopies.

To view this special video series, “No Ifs, And, or Butts,” please visit http://www.curetoday.com/insights/colorectal-cancer-screening.

About CURE Media Group
CURE Media Group is the leading resource for cancer updates, research and education. It combines a full suite of media products, including its industry-leading website, CUREtoday.com; innovative video programs, such as CURE Connections®; a series of widely attended live events; and CURE® magazine, which reaches over 1 million readers. CURE Media Group is part of the Cranbury, New Jersey-based Michael J. Hennessy Associates, Inc., family of businesses, which includes the acclaimed OncLive® (http://www.onclive.com) platform of resources for the practicing oncologist. For more information, visit http://www.curetoday.com or http://www.mjhassoc.com.

MJH Studios™
MJH Studios™ is a world-class production facility and resource center dedicated to the development and distribution of original content, MJH Studios™ is part of the Michael J. Hennessy Associates, Inc. family of businesses, which includes Cure Media Group® (http://www.curetoday.com/), Onclive® (http://www.onclive.com) and Pharmacy Times® (http://www.pharmacytimes.com/), and is conveniently located in Cranbury, New Jersey. For more information, visit http://www.MJH-studios.com or http://www.mjhassoc.com.

Read the full story at http://www.prweb.com/releases/2017/03/prweb14175074.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. Mediaplanet to Release Call-To-Action Campaign Encouraging Americans to Invest in Disaster Relief in the Developing World
2. Beverly Hills Public Relations: Special Rate for Social Media Management
3. Infertility Meets Social Media in a Virtual Video Contest to Win a Donated IVF Cycle
4. News media reinforce sexual exploitation stereotypes
5. BeachLifestyle and The Total Education Network Announce Their Partnership as the Simply G Media Network
6. Mediaplanet's Careers in Healthcare
7. BTV-Business Television features Google and Up and Comers: Exco, Clean Seed, LED Medical, Destiny Media and Natcore
8. Nuanced Media Client, Andrea Blatterg of of ABC Senior Placement Advisors Presents: Wildflower Group’s November Event, "Exploring the Allure of Senior Living"
9. Effect of reducing blood pressure with medications immediately following ischemic stroke
10. New ISHLT nomenclature & diagnostic criteria: Antibody-mediated rejection in heart transplantation
11. Influence of pro-smoking media messages lasts 7 days, study finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Apple ... care services, staged a mock evacuation of the facility as part of a disaster ... Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well as the ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at ... of the most popular and least understood books in the Holy Scriptures, Revelation. The ... that have baffled scholars for centuries. Many have tossed it off as mere rubbish, ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance (FHC), an ... showcase a range of technology and learning solutions at the 68th Annual American ... to be held October 14–18, 2017 at the Mandalay Bay Resort in Las ...
(Date:10/12/2017)... , ... October 12, 2017 , ... The American College ... to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in ... , In honor of Morris F. Collen, a pioneer in the field of medical ...
(Date:10/12/2017)... ... , ... Leading pediatric oncology experts at Children’s National Health System ... of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by ... Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief of the ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Diplomat Pharmacy, Inc. (NYSE: DPLO ... LLC , and named its founder as Diplomat,s chief ... Tennessee , will operate under Diplomat subsidiary ... offerings for health care partners to include IT outsourcing, ... "In an interoperable world, technology delivers comprehensive insight ...
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, Inc. ... earnings conference call and webcast on Friday, November 3, ... (EDT) and ending at approximately 8:30 a.m. (CDT) / ... the company,s 2017 financial performance and guidance for 2018, ... initiatives to enhance operational performance, and long-range financial outlook ...
(Date:9/25/2017)... PROVIDENCE, R.I. , Sept. 25, 2017 /PRNewswire/ ... immunogenicity assessment, vaccine design, and immune-engineering today announced ... focused on the development of personalized therapeutic cancer ... and has provided exclusive access to enabling technologies ... MSc Eng., MBA will lead EpiVax Oncology as ...
Breaking Medicine Technology: